Page last updated: 2024-10-31

neostigmine and Liver Steatosis

neostigmine has been researched along with Liver Steatosis in 1 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carron, M1
Parotto, E1
Ori, C1

Other Studies

1 other study available for neostigmine and Liver Steatosis

ArticleYear
Prolonged neuromuscular block associated to non-alcoholic steatohepatitis in morbidly obese patient: neostigmine versus sugammadex.
    Minerva anestesiologica, 2012, Volume: 78, Issue:1

    Topics: Adult; Biopsy; Cholinesterase Inhibitors; Fatty Liver; gamma-Cyclodextrins; Humans; Male; Monitoring

2012